OOIR: Observatory of International Research

Papers

(The TQCC of Gut Pathogens is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Dietary patterns drive loss of fiber-foraging species in the celiac disease patients gut microbiota compared to first-degree relatives	164
A fatal case of Vibrio cholerae-associated diarrhea and bacteremia in a 30-year-old carrier of beta-thalassemia	86
Clonal and horizontal transmission of carbapenem-resistant Enterobacterales strains and genes via flies	56
A monoclonal antibody collection for C. difficile typing ?	46
Invasion of intestinal cells by Staphylococcus warneri, a member of the human gut microbiota	35
Significant abundance of bacterial flagellin and expression of its surface localized receptor toll-like receptor 5 and cytokine interleukin-22 in South African infants with poor oral rotavirus vaccine	34
A case–control study of the association between the gut microbiota and colorectal cancer: exploring the roles of diet, stress, and race	33
Assessing the impact of storage time on the stability of stool microbiota richness, diversity, and composition	31
The emerging role of neutrophilic extracellular traps in intestinal disease	29
Profile of intestinal fungal microbiota in acute pancreatitis patients and healthy individuals	26
Intestinal metabolites predict treatment resistance of patients with depression and anxiety	26
Translocating lipopolysaccharide correlates with the severity of enterovirus A71-induced HFMD by promoting pro-inflammation and viral IRES activity	26
Equol: a metabolite of gut microbiota with potential antitumor effects	26
Elucidating antibiofilm as well as photocatalytic disinfection potential of green synthesized nanosilver against multi-drug-resistant bacteria and its photodegradation ability of cationic dyes	25
Interaction between PSMD10 and GRP78 accelerates endoplasmic reticulum stress-mediated hepatic apoptosis induced by homocysteine	24
Bioengineering of LAB vector expressing Haemolysin co-regulated protein (Hcp): a strategic approach to control gut colonization of Campylobacter jejuni in a murine model	24
Comparative genomic characterization of multidrug-resistant Citrobacter spp. strains in Fennec fox imported to China	23
Characteristics of ESBL-positive Klebsiella pneumoniae isolated from paired children with and without diarrhea	23
The role of non-Helicobacter pylori bacteria in the pathogenesis of gastroduodenal diseases	23
Retrospective analysis of Clostridioides difficile and other intestinal infections in patients with Crohn’s disease and ulcerative colitis in the tertiary hospital in Poland. POLIBD survey results	23
A prospective investigation into the association between the gut microbiome composition and cognitive performance among healthy young adults	22
Fecal microbiome alterations of mice following immunization with gold nanoparticle vaccines against enterohemorrhagic Escherichia coli	22
Pathogenetic detection, retrospective and pathogenicity analysis of a fatal case of Vibrio vulnificus in Shenzhen, China	21
Impact of invasive infections on clinical outcomes in acute pancreatitis: early predictive factors and implications for prophylactic anti-infective therapy	21
A systematic review and meta-analysis of protozoan parasite infections among patients with mental health disorders: an overlooked phenomenon	20

Correction: Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease	20
Fecal glycoprotein 2 is a marker of gut microbiota dysbiosis and systemic inflammation	19
Helicobacter pylori infection: is there circulating vacuolating cytotoxin A or cytotoxin-associated gene A protein?	19
Potential impact of gut Lactobacillus acidophilus and Bifidobacterium bifidum on hepatic histopathological changes in non-cirrhotic hepatitis C virus patients with different viral load	18
Recent five-year progress in the impact of gut microbiota on vaccination and possible mechanisms	17
Genomes of Vibrio metoecus co-isolated with Vibrio cholerae extend our understanding of differences between these closely related species	17
One health pathogen surveillance demonstrated the dissemination of gut pathogens within the two coastal regions associated with intensive farming	16
Genomic analysis of halophilic bacterium, Lentibacillus sp. CBA3610, derived from human feces	15
Antimicrobial growth promoters approved in food-producing animals in South Africa induce shiga toxin-converting bacteriophages from Escherichia coli O157:H7.	15
Genome insights of Enterococcus raffinosus CX012922, isolated from the feces of a Crohn’s disease patient	15
Dysbiosis of gut microbiota during fecal stream diversion in patients with colorectal cancer	14
Overview of pathogenic Escherichia coli, with a focus on Shiga toxin-producing serotypes, global outbreaks (1982–2024) and food safety criteria	14
Management of dyspepsia and Helicobacter pylori infection: the 2022 Indonesian Consensus Report	14
Prevalence of intestinal parasites and Helicobacter pylori coinfection, and contributing factors among patients with gastrointestinal manifestations at Addis Zemen primary hospital, Northwest Ethiopia	14
The immune-adjunctive potential of recombinant LAB vector expressing murine IFNλ3 (MuIFNλ3) against Type A Influenza Virus (IAV) infection	13
16S rRNA sequencing analysis of the oral and fecal microbiota in colorectal cancer positives versus colorectal cancer negatives in Iranian population	13
Bacteremia from streptococcus constellatus revealing a gastrointestinal stromal tumor	13
Metagenomics: a new frontier for routine pathology testing of gastrointestinal pathogens	13
Risk factors and clinical outcomes associated with multiple as opposed to single pathogens detected on the gastrointestinal disease polymerase chain reaction assay	13
In silico molecular docking and in vitro antimicrobial efficacy of phytochemicals against multi-drug-resistant enteroaggregative Escherichia coli and non-typhoidal Salmonella spp.	13
A triad of gut dysbiosis, dysregulated immunity, and ‘leaky’ gut characterize HCMV associated neonatal cholestasis	13
Impact of azithromycin mass drug administration on the antibiotic-resistant gut microbiome in children: a randomized, controlled trial	12
The effects of probiotic treatment with Bifidobacterium breve, Bif195 for small intestinal Crohn’s disease and the gut microbiome: results from a randomised, double-blind, placebo-controlled trial	12
Investigation and characterization of human gut phageome in advanced liver cirrhosis of defined etiologies	11
Comparative genomics of Campylobacter jejuni from clinical campylobacteriosis stool specimens	11
Etiology of diarrheal hospitalizations following rotavirus vaccine implementation and association of enteric pathogens with malnutrition among under-five children in India	11
Genomic insights into zoonotic transmission and antimicrobial resistance in Campylobacter jejuni from farm to fork: a one health perspective	11
Clinical manifestations, risk factors, and prognostic factors of cytomegalovirus enteritis	10
Antibiotic resistance and detection of plasmid mediated colistin resistance mcr-1 gene among Escherichia coli and Klebsiella pneumoniae isolated from clinical samples	10
Comparison of antimicrobial resistant Escherichia coli isolated from Irish commercial pig farms with and without zinc oxide and antimicrobial usage	10
The use of biomarkers associated with leaky gut as a diagnostic tool for early intervention in autism spectrum disorder: a systematic review	10
Correlation between gut microbiota composition, enteric infections and linear growth impairment: a case–control study in childhood stunting in Pidie, Aceh, Indonesia	9
Effect of probiotic supplementation on gastrointestinal motility, inflammation, motor, non-motor symptoms and mental health in Parkinson’s disease: a meta-analysis of randomized controlled trials	9
miR-125a-5p regulates the sialyltransferase ST3GAL1 in murine model of human intestinal campylobacteriosis	9
High-dose dual therapy for Helicobacter pylori eradication inducing less impact on the gut microbiota	9
Timing and clinical risk factors for early acquisition of gut pathogen colonization with multidrug resistant organisms in the intensive care unit	9
Dynamic changes in the gut microbiota composition during adalimumab therapy in patients with ulcerative colitis: implications for treatment response prediction and therapeutic targets	9
Gut microbiota imbalance in colorectal cancer patients, the risk factor of COVID-19 mortality	9
Correction: Recent five-year progress in the impact of gut microbiota on vaccination and possible mechanisms	9
Changes in the gut bacterial communities in colon cancer surgery patients: an observational study	9
Genetic evolution and phylogenetic analysis of porcine epidemic diarrhea virus strains circulating in and outside China with reference to a wild type virulent genotype CHYJ130330 reported from Guangdo	9
Genomic characterization of nine Clostridioides difficile strains isolated from Korean patients with Clostridioides difficile infection	9
Clostridioides difficile toxin is infrequently detected in inflammatory bowel disease and does not associate with clinical outcomes	8
Development of the gut microbiota during early life in premature and term infants	8
Detrimental relevance of Helicobacter pylori infection with sarcopenia	8
Depletion of core microbiome forms the shared background against diverging dysbiosis patterns in Crohn’s disease and intestinal tuberculosis: insights from an integrated multi-cohort analysis	8
Risk factors for gut colonization with vancomycin-resistant enterococci among Bulgarian critically ill patients	8
Obesity is not associated with adverse outcomes among hospitalized patients with Clostridioides difficile infection	8
Elevated plasma and bile levels of corisin, a microbiota-derived proapoptotic peptide, in patients with severe acute cholangitis	8
The gut microbiome, resistome, and mycobiome in preterm newborn infants and mouse pups: lack of lasting effects by antimicrobial therapy or probiotic prophylaxis	8

Case report: Aberrant fecal microbiota composition of an infant diagnosed with prolonged intestinal botulism	8
Role of fecal calprotectin as a hypoxic intestinal damage biomarker in COVID-19 patients	8
Epidemiological characteristics and genetic diversity of norovirus infections among outpatient children with diarrhea under 5 years of age in Beijing, China, 2011–2018	8